NANCY A. BENSINGER
Denver,CO
Summary
Accomplished Strategic Account Manager dedicated to opening new accounts & managing the health of existing accounts. Strategically works to remove barriers to access and product misconceptions. Continually analyzing sales data, market data and staying on top of trends. Creative problem-solver, always looking at new, compliant, ways to meet and exceed customer’s expectations. Strong communicator and collaborator both externally and cross functionally along with being fully engaged to build long-term, trusting business relationships to improve sales and customer satisfaction.
Overview
34
34
years of professional experience
Work History
Strategic Account Manager – Market Access - Radioligand Therapies, Rare Disease, Complex Therapeutics - Lutathera, Pluvicto
NOVARTIS CORPORATION
11.2019 - Current
- Operationalize new RLT centers - assessing, establishing and optimizing for growth within rare disease of neuroendocrine cancer and prostate cancer radioligand therapy portfolio
- Lead multidisciplinary meetings with key stakeholders including C Suite, Nuclear Medicine, Radiation Oncology, Nuclear Technologists, Pharmacy, Revenue Cycle & internal Novartis stakeholders
- Initiate contracting and terms along with Buy & Bill, 340b, GPO rebate scenarios
- Discuss process & workflow sharing best practices
- Conduct executive exchanges with key business stakeholders - account business reviews
- Procurement and management of RLT doses - Provide continual updates between Novartis and Treatment Sites of logistics, updates and future of deliveries
- Health of treatment Center – Patients & workflow, reimbursement, updating account information within Novartis Systems
- Fully Onboarded and set up over 20 treating sites across my territory while effectively managing all aspects of
- Successfully managed through previous manufacturing shortages & disruption – by continual communication, working closely with internal and external customers to strengthen supply chain confidence
- Collaborate & run biweekly meetings with internal stakeholders - Oncology Specialists, Medical Science Liaisons, Radioligand Therapy Specialists, Market Access & Reimbursement, Director of National Accounts, Area Business Leads
- Connecting Novartis resources with accounts to enhance RLT program efficiencies for the accounts and patients
- Top Accounts & Healthcare Systems Operationalized/Managed: University of Colorado – Anschutz, Denver; University of New Mexico, Albuquerque; University of Arizona, Banner Health, Tucson; UC Health – Poudre Valley – Ft
- Collins; UC Health Memorial – Colorado Springs; University of Utah – Huntsman Cancer – Salt Lake City; IHC Hospitals – Utah, Nevada, Colorado; St
- Lukes Hospital – Boise; Rocky Mountain Cancer Centers – Denver; US Oncology – Tucson & Denver; Community Hospital, Grand Junction; Billings Hospital – Billings; New Mexico Hem/Onc
- Albuquerque; University of Iowa, Iowa Falls; St
- Mary’s Hospital , Grand Junction; Rocky Mountain Oncology - Casper; United Urology, Denver; Rio Grande Urology, El Paso
RLT Oncology Account Sales Specialist, Diagnostic Sales Specialist, Complex Matrix Collaborator
ADVANCED ACCELERATOR APPLICATIONS (A Novartis Company
11.2019 - 07.2021
- Responsible for sales of Lutathera for rare disease, GEP-NETS in Academic Centers, Community Hospitals and Community Clinics
- Exponential sales growth of Lutathera in new and existing sites
- Sold into and onboarded over 17 Lutathera treating sites in CO, UT, KS, SD, IA, MT
- 2022 Impact Award Winner
- 2022 Promoted from Oncology Account Manager to Strategic Account Manager
- Invited to present at National Sales Meeting
- Lutathera and NETSPOT Regional Sales Trainer
- Identified and continued to help develop several key Lutathera KOL’s as keynote speakers with our marketing team
- Member of Managed Markets Team
Precision Oncology Sales Consultant
BAYER ONCOLOGY
05.2019 - 11.2019
- Sold rare disease targeted precision oncology product, Vitrakvi and hematology product, Aliqopa in CO, WY and NE to hematologists, oncologists, Children’s Hospitals and community hospitals
- Worked with genomic testing partners, specialty pharmacies, 3rd party vendors, and various levels of management both internal and external
- Identified, sold and onboarded 4 Vitrakvi, rare NTRK, fusion patients in first 5 months of position
Regional Sales Manager
BLUE EARTH DIAGNOSTICS/BRACCO DIAGNOSTICS
11.2018 - 05.2019
- Launched and sold a novel radiopharmaceutical (Axumin) used with PET/CT for diagnosing and precision treatment of prostate cancer
- Covered CO, NM, WY, MN
- Sold to Urologists, Oncologists, Radiation Oncologists, Nuclear Medicine physicians, LUGPA, imaging sites and Cardinal pharmacy
- Provided reimbursement/coding, managed care policy and bundling pricing support
- 104% to goal for October to December, 2018
Immunology/Oncology Sales and Reimbursement Specialist
DENDREON
11.2015 - 11.2018
- Promoted and educated accounts on Provenge (immunotherapy) covering CO, WY and NM
- Sold to oncologists, urologists, Nurse Navigators and medical staff and provided education of product, ordering, working with logistics, appropriate billing and reimbursement procedures along with patient support programs
- Reduced reimbursement barriers for office billing by providing payor policy information, position of Provenge on each, step edits, PA’s, appeal process, EMR build
- Worked with Revenue Cycle Managers, partnered with our National Accounts Team to identify and rectify denials and improve policy restrictions, appeals, underpayments, and PA’s along with State Medicaid and Medicare plans for coverage of product
- Worked closely with Marketing to plan a better strategy for sales and patient education regarding process in apheresis centers to save time and provide better patient comfort
- 140% to goal for January – August, 2018
Specialty Sales Representative
DEPOMED
09.2011 - 11.2015
Oncology Sales
BRISTOL MYERS SQUIBB/INVENTIV CONTRACT
09.2010 - 09.2011
Specialty Pain Sales Representative
ENDO PHARMACEUTICALS
05.2002 - 09.2010
Sales Specialist
BRISTOL MYERS SQUIBB
04.1999 - 05.2002
Specialty Pain Sales Specialist
PURDUE PHARMA
02.1990 - 07.1995
Education
Bachelor of Science (BS) - Communications/Marketing
Missouri State University
Springfield, MOSkills
- Pipeline Management
- Competitive Analysis
- Brand positioning
- Technical Sales Support
Timeline
Strategic Account Manager – Market Access - Radioligand Therapies, Rare Disease, Complex Therapeutics - Lutathera, Pluvicto
NOVARTIS CORPORATION
11.2019 - Current
RLT Oncology Account Sales Specialist, Diagnostic Sales Specialist, Complex Matrix Collaborator
ADVANCED ACCELERATOR APPLICATIONS (A Novartis Company
11.2019 - 07.2021
Precision Oncology Sales Consultant
BAYER ONCOLOGY
05.2019 - 11.2019
Regional Sales Manager
BLUE EARTH DIAGNOSTICS/BRACCO DIAGNOSTICS
11.2018 - 05.2019
Immunology/Oncology Sales and Reimbursement Specialist
DENDREON
11.2015 - 11.2018
Specialty Sales Representative
DEPOMED
09.2011 - 11.2015
Oncology Sales
BRISTOL MYERS SQUIBB/INVENTIV CONTRACT
09.2010 - 09.2011
Specialty Pain Sales Representative
ENDO PHARMACEUTICALS
05.2002 - 09.2010
Sales Specialist
BRISTOL MYERS SQUIBB
04.1999 - 05.2002
Specialty Pain Sales Specialist
PURDUE PHARMA
02.1990 - 07.1995
Bachelor of Science (BS) - Communications/Marketing
Missouri State University
Similar Profiles
Luis CalderonLuis Calderon
ASSOCIATE DIRECTOR – DISEASE CLINICAL SPECIALIST at Novartis CorporationASSOCIATE DIRECTOR – DISEASE CLINICAL SPECIALIST at Novartis Corporation
Hal HendersonHal Henderson
Regional Sales Director at Novartis CorporationRegional Sales Director at Novartis Corporation
Stephanie Golden-GamarraStephanie Golden-Gamarra
Associate Director, Access & Reimbursement at Novartis Pharmaceuticals CorporationAssociate Director, Access & Reimbursement at Novartis Pharmaceuticals Corporation
Kristopher ColemanKristopher Coleman
Project Manager at Murphy CompanyProject Manager at Murphy Company
Jessica SheheenJessica Sheheen
Bartender/Server at Blue Island Oyster BarBartender/Server at Blue Island Oyster Bar